NO324229B1 - 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse - Google Patents
2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelseInfo
- Publication number
- NO324229B1 NO324229B1 NO20024745A NO20024745A NO324229B1 NO 324229 B1 NO324229 B1 NO 324229B1 NO 20024745 A NO20024745 A NO 20024745A NO 20024745 A NO20024745 A NO 20024745A NO 324229 B1 NO324229 B1 NO 324229B1
- Authority
- NO
- Norway
- Prior art keywords
- hydroxymutiline
- preparing
- compound
- pharmaceutical composition
- carbamate derivatives
- Prior art date
Links
- 150000004657 carbamic acid derivatives Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0008260.2A GB0008260D0 (en) | 2000-04-04 | 2000-04-04 | Novel compounds |
| GB0027182A GB0027182D0 (en) | 2000-11-04 | 2000-11-04 | Novel comounds |
| PCT/EP2001/003594 WO2001074788A1 (en) | 2000-04-04 | 2001-03-29 | 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20024745D0 NO20024745D0 (no) | 2002-10-02 |
| NO20024745L NO20024745L (no) | 2002-11-19 |
| NO324229B1 true NO324229B1 (no) | 2007-09-10 |
Family
ID=26244040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024745A NO324229B1 (no) | 2000-04-04 | 2002-10-02 | 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6972297B2 (enExample) |
| EP (1) | EP1268443B1 (enExample) |
| JP (1) | JP2003529593A (enExample) |
| KR (1) | KR100758441B1 (enExample) |
| CN (1) | CN1210267C (enExample) |
| AR (1) | AR030203A1 (enExample) |
| AT (1) | ATE437860T1 (enExample) |
| AU (2) | AU2001263827B2 (enExample) |
| BR (1) | BR0109809A (enExample) |
| CA (1) | CA2405132A1 (enExample) |
| CO (1) | CO5280223A1 (enExample) |
| CZ (1) | CZ20023290A3 (enExample) |
| DE (1) | DE60139382D1 (enExample) |
| ES (1) | ES2328109T3 (enExample) |
| HU (1) | HUP0300370A3 (enExample) |
| IL (1) | IL151887A0 (enExample) |
| MX (1) | MXPA02009816A (enExample) |
| NO (1) | NO324229B1 (enExample) |
| NZ (1) | NZ521536A (enExample) |
| PL (1) | PL358666A1 (enExample) |
| WO (1) | WO2001074788A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0024811D0 (en) | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
| US7176310B1 (en) | 2002-04-09 | 2007-02-13 | Ucb Sa | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents |
| GB0209262D0 (en) * | 2002-04-23 | 2002-06-05 | Biochemie Gmbh | Organic compounds |
| AU2003257493A1 (en) * | 2002-07-24 | 2004-02-16 | Sandoz Ag | Pleuromutilin derivatives as antimicrobbials |
| GB0218578D0 (en) * | 2002-08-09 | 2002-09-18 | Glaxo Group Ltd | Novel method |
| GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
| FR2856685B1 (fr) * | 2003-06-25 | 2005-09-23 | Merck Sante Sas | Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2008523016A (ja) * | 2004-12-13 | 2008-07-03 | グラクソ グループ リミテッド | （５−アミノ−６−メトキシ−３−ピリジンカルボニル）カルバミン酸２−（ｓ）−ヒドロキシムチリン１４−エステルの新規の多形 |
| EP1832591A1 (en) * | 2004-12-27 | 2007-09-12 | Kyorin Pharmaceutical Co., Ltd. | 12-position substituted mutilin derivative |
| US20080139626A1 (en) * | 2005-03-10 | 2008-06-12 | Rittenhouse Stephen F | Novel Method |
| TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| KR100695541B1 (ko) * | 2005-10-31 | 2007-03-16 | 한국단자공업 주식회사 | 연결터미널 |
| WO2007079173A2 (en) * | 2005-12-30 | 2007-07-12 | Emergent Biosolutions Inc. | Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents |
| EP2149571A4 (en) * | 2007-05-24 | 2010-09-01 | Kyorin Seiyaku Kk | MUTILINE DERIVATIVE WITH A RINGED, HETEROCYCLIC AND AROMATIC CARBOXYLIC ACID STRUCTURE IN A SUBSTITUTE AT POSITION 14 |
| EP2014640A1 (en) * | 2007-07-13 | 2009-01-14 | Nabriva Therapeutics AG | Pleuromutilin derivatives |
| JP2010100582A (ja) * | 2008-10-24 | 2010-05-06 | Kyorin Pharmaceut Co Ltd | １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体 |
| EP2184273A1 (de) | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| EP2253617A1 (de) | 2009-05-20 | 2010-11-24 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| JP6818019B2 (ja) * | 2015-06-17 | 2021-01-20 | ナブリヴァ セラピュティクス ゲーエムベーハー | レファムリンの注射可能医薬組成物 |
| CA3130138A1 (en) * | 2019-02-27 | 2020-09-03 | Oticara, Inc. | Method for treating nasal, sinonasal, and nasopharyngeal tissue infection and/or inflammation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9900973A3 (en) * | 1996-01-03 | 2000-04-28 | Smithkline Beecham Plc | Carbamoyloxy derivatives of mutiline with antibacterial activity, pharmaceutical compns. contg. them and process for preparing the said compds. |
| HUP0001741A3 (en) * | 1996-08-02 | 2000-11-28 | Smithkline Beecham Plc | Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use |
| UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
| FR2771008B1 (fr) | 1997-11-17 | 2000-04-28 | Hoechst Marion Roussel Inc | Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose |
| GB9817029D0 (en) * | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
-
2001
- 2001-03-29 CA CA002405132A patent/CA2405132A1/en not_active Abandoned
- 2001-03-29 AT AT01938069T patent/ATE437860T1/de not_active IP Right Cessation
- 2001-03-29 CN CNB018091989A patent/CN1210267C/zh not_active Expired - Fee Related
- 2001-03-29 HU HU0300370A patent/HUP0300370A3/hu unknown
- 2001-03-29 AU AU2001263827A patent/AU2001263827B2/en not_active Ceased
- 2001-03-29 WO PCT/EP2001/003594 patent/WO2001074788A1/en not_active Ceased
- 2001-03-29 NZ NZ521536A patent/NZ521536A/en unknown
- 2001-03-29 PL PL01358666A patent/PL358666A1/xx not_active Application Discontinuation
- 2001-03-29 US US10/240,908 patent/US6972297B2/en not_active Expired - Fee Related
- 2001-03-29 BR BR0109809-8A patent/BR0109809A/pt not_active Application Discontinuation
- 2001-03-29 CZ CZ20023290A patent/CZ20023290A3/cs unknown
- 2001-03-29 AU AU6382701A patent/AU6382701A/xx not_active Withdrawn
- 2001-03-29 ES ES01938069T patent/ES2328109T3/es not_active Expired - Lifetime
- 2001-03-29 DE DE60139382T patent/DE60139382D1/de not_active Expired - Lifetime
- 2001-03-29 JP JP2001572483A patent/JP2003529593A/ja active Pending
- 2001-03-29 IL IL15188701A patent/IL151887A0/xx unknown
- 2001-03-29 EP EP01938069A patent/EP1268443B1/en not_active Expired - Lifetime
- 2001-03-29 MX MXPA02009816A patent/MXPA02009816A/es active IP Right Grant
- 2001-03-29 KR KR1020027013202A patent/KR100758441B1/ko not_active Expired - Fee Related
- 2001-03-30 AR ARP010101559A patent/AR030203A1/es not_active Application Discontinuation
- 2001-03-30 CO CO01025487A patent/CO5280223A1/es not_active Application Discontinuation
-
2002
- 2002-10-02 NO NO20024745A patent/NO324229B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02009816A (es) | 2003-03-27 |
| ATE437860T1 (de) | 2009-08-15 |
| HUP0300370A3 (en) | 2005-07-28 |
| PL358666A1 (en) | 2004-08-09 |
| CO5280223A1 (es) | 2003-05-30 |
| CN1427827A (zh) | 2003-07-02 |
| HUP0300370A2 (hu) | 2003-06-28 |
| KR100758441B1 (ko) | 2007-09-14 |
| US6972297B2 (en) | 2005-12-06 |
| NO20024745D0 (no) | 2002-10-02 |
| AR030203A1 (es) | 2003-08-13 |
| NO20024745L (no) | 2002-11-19 |
| JP2003529593A (ja) | 2003-10-07 |
| WO2001074788A1 (en) | 2001-10-11 |
| CN1210267C (zh) | 2005-07-13 |
| DE60139382D1 (de) | 2009-09-10 |
| KR20030011815A (ko) | 2003-02-11 |
| US20030114674A1 (en) | 2003-06-19 |
| CZ20023290A3 (cs) | 2003-03-12 |
| ES2328109T3 (es) | 2009-11-10 |
| NZ521536A (en) | 2004-05-28 |
| AU6382701A (en) | 2001-10-15 |
| WO2001074788A8 (en) | 2001-12-20 |
| IL151887A0 (en) | 2003-04-10 |
| AU2001263827B2 (en) | 2004-06-17 |
| BR0109809A (pt) | 2003-01-21 |
| CA2405132A1 (en) | 2001-10-11 |
| EP1268443B1 (en) | 2009-07-29 |
| EP1268443A1 (en) | 2003-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO324229B1 (no) | 2-hydroksymutilinkarbamat-derivater, anvendelse derav, farmasoytisk sammensetning samt fremgangsmate for fremstilling av en slik forbindelse | |
| NO20085078L (no) | Nye forbindelser | |
| ATE181551T1 (de) | Taxol-derivate | |
| FI962418A0 (fi) | Syklisiä amidijohdannaisia neurokiniini A antagonisteina | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| NO951198D0 (no) | Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene | |
| DE69705300D1 (de) | Cyclopropylalkansäurederivate | |
| NO970512L (no) | Nye heteroaryl-oksazolidinoner | |
| NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| DE69735634D1 (de) | Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind | |
| HUP0001269A2 (hu) | 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| ATE122654T1 (de) | Behandlung von hiv-infizierungen und nützliche verbindungen dafür. | |
| NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
| DK0992509T3 (da) | Nye makrolid-derivater | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO960632L (no) | Nye bis-naftalimider for behandling av kreft | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| RU94046387A (ru) | Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты | |
| DE59108566D1 (de) | Heteroarylmethylbenzole-Aromatasehemmer | |
| NO986186D0 (no) | <Beta> <beta>-disubstituerte derivater av 9-deokso-9a-n-etetnyl-9a-aza-9a-homoerytromycin a | |
| DE60021109D1 (de) | Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel | |
| DE69908855D1 (de) | 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin | |
| HUP0302901A2 (hu) | Cianoaril-(vagy cianoheteroaril)-karbonil-piperazinil-pirimidinek új származékai, előállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |